Insights

Loading spinner
Gathering insights about Palleon Pharmaceuticals

Palleon Pharmaceuticals Tech Stack

Palleon Pharmaceuticals uses 8 technology products and services including Adobe Fonts, Twitter Emoji (Twemoji), jQuery Migrate, and more. Explore Palleon Pharmaceuticals's tech stack below.

  • Adobe Fonts
    Font Scripts
  • Twitter Emoji (Twemoji)
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • RSS
    Miscellaneous
  • WP Engine
    Platform As A Service
  • Cloudflare Bot Management
    Security
  • ZURB Foundation
    UI Frameworks

Media & News

Palleon Pharmaceuticals's Email Address Formats

Palleon Pharmaceuticals uses at least 1 format(s):
Palleon Pharmaceuticals Email FormatsExamplePercentage
FLast@palleonpharma.comJDoe@palleonpharma.com
49%
First.Last@palleonpharma.comJohn.Doe@palleonpharma.com
1%
First@palleonpharma.comJohn@palleonpharma.com
1%
FLast@palleonpharma.comJDoe@palleonpharma.com
49%

Frequently Asked Questions

Where is Palleon Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Palleon Pharmaceuticals's main headquarters is located at 266 Second Ave Waltham, Massachusetts 02451 US. The company has employees across 3 continents, including North AmericaSouth AmericaAsia.

What is Palleon Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Palleon Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Palleon Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Palleon Pharmaceuticals's official website is palleonpharma.com and has social profiles on LinkedIn.

How much revenue does Palleon Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of October 2024, Palleon Pharmaceuticals's annual revenue reached $3.8M.

What is Palleon Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Palleon Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Palleon Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of October 2024, Palleon Pharmaceuticals has approximately 27 employees across 3 continents, including North AmericaSouth AmericaAsia. Key team members include Chief Scientific Officer: L. P.Chief Scientific Officer: K. C.Vice President Of Cmc: M. Y.. Explore Palleon Pharmaceuticals's employee directory with LeadIQ.

What industry does Palleon Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Palleon Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Palleon Pharmaceuticals use?

Minus sign iconPlus sign icon
Palleon Pharmaceuticals's tech stack includes Adobe FontsTwitter Emoji (Twemoji)jQuery MigratejQueryRSSWP EngineCloudflare Bot ManagementZURB Foundation.

What is Palleon Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Palleon Pharmaceuticals's email format typically follows the pattern of . Find more Palleon Pharmaceuticals email formats with LeadIQ.

How much funding has Palleon Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of October 2024, Palleon Pharmaceuticals has raised $100M in funding. The last funding round occurred on Sep 17, 2020 for $100M.

When was Palleon Pharmaceuticals founded?

Minus sign iconPlus sign icon
Palleon Pharmaceuticals was founded in 2016.
Palleon Pharmaceuticals

Palleon Pharmaceuticals

Biotechnology ResearchMassachusetts, United States11-50 Employees

Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glyco-Immune Checkpoint inhibitors to treat cancer.
 
The company’s proprietary Convergence Platform integrates technologies and insights from world-renowned scientific leaders in the fields of glycoscience and human immunology to create a novel approach to treating cancer. By targeting multiple immune cell types, Glyco-Immune Checkpoint inhibitors will tackle resistance to first-generation immuno-oncology agents, and make possible a wider range of rational combination therapies to treat cancer. While Palleon is focused primarily on oncology, the Convergence Platform is applicable to other therapeutic areas including infectious diseases, neurodegeneration, inflammation, and fibrosis.
 
The company is advancing its pipeline and development programs with a $47.6 million Series A financing from leading biotech venture investors SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, and AbbVie Ventures.

Section iconCompany Overview

Headquarters
266 Second Ave Waltham, Massachusetts 02451 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $100M

    Palleon Pharmaceuticals has raised a total of $100M of funding over 2 rounds. Their latest funding round was raised on Sep 17, 2020 in the amount of $100M.

  • $10M

    Palleon Pharmaceuticals's revenue is in the range of $10M

Section iconFunding & Financials

  • $100M

    Palleon Pharmaceuticals has raised a total of $100M of funding over 2 rounds. Their latest funding round was raised on Sep 17, 2020 in the amount of $100M.

  • $10M

    Palleon Pharmaceuticals's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.